Talecris shareholders approve planned merger with Grifols

02/15/2011 | News & Observer (Raleigh, N.C.), The

Talecris Biotherapeutics shareholders on Monday gave the nod for the company's planned merger with Spanish firm Grifols. The Federal Trade Commission still is reviewing the plan to ensure that it will not lead to an increase in prices of blood plasma-based drugs. Wall Street analysts are confident the deal will push through.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC